AVIR
Atea Pharmaceuticals, Inc. · Healthcare
President, CEO and Chair Jean-Pierre Sommadossi sold $219K of Atea Pharmaceuticals, Inc.
Sold$218,819
$3.85Price
56,910Shares
−1%Stake
What AVIR did after the filing
- The stock from Mon, Feb 5 open, $4.06
- −3.0%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Feb 1. Filed Fri, Feb 2, 4:30 PM ET, after the close. Returns use the Feb 5 open and the Mar 19 close. Not investment advice.